ELAC2

gene product
FLJ10530, HPC2
The protein encoded by this gene has a C-terminal domain with tRNA 3′ processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
179 antibodies from 27 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
1 antibody
Novus Biologicals
4 antibodies
GeneTex
3 antibodies
antibodies-online
69 antibodies
Invitrogen Antibodies
3 antibodies
LifeSpan BioSciences, Inc.
40 antibodies
Bethyl Laboratories
2 antibodies
Biorbyt
14 antibodies
St John's Laboratory
2 antibodies
Bioworld Technology, Inc
1 antibody
Abnova Corporation
5 antibodies
OriGene
3 antibodies
Affinity Biosciences
1 antibody
NovoPro Bioscience Inc.
1 antibody
Proteintech Group
1 antibody
Acris Antibodies GmbH
2 antibodies
Aviva Systems Biology
2 antibodies
MyBioSource
2 antibodies
Boster Biological Technology
1 antibody
Sigma-Aldrich
3 antibodies
Creative Diagnostics
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Creative Biolabs
1 antibody
RayBiotech, Inc.
1 antibody
ProSci
1 antibody
United States Biological
1 antibody